Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:pharmaceuticals
|
| gptkbp:approves |
not approved yet
|
| gptkbp:clinical_phase |
Phase 2
|
| gptkbp:developed_by |
gptkb:Medi_Gene_AG
|
| https://www.w3.org/2000/01/rdf-schema#label |
MGL-202
|
| gptkbp:indication |
gptkb:Oncology
|
| gptkbp:mechanism_of_action |
targeting HER2
|
| gptkbp:route_of_administration |
intravenous
|
| gptkbp:status |
investigational
|
| gptkbp:targets |
gptkb:HER2
|
| gptkbp:type |
gptkb:monoclonal_antibody
|
| gptkbp:bfsParent |
gptkb:Milkor_MGL
|
| gptkbp:bfsLayer |
8
|